Efficacy of up-front 5-fluorouracil – epidoxorubicin – cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients
Open Access
- 1 May 1996
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 73 (9) , 1080-1085
- https://doi.org/10.1038/bjc.1996.208
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cmCancer, 1994
- Management of locally advanced carcinoma of the breast I. NoninflammatoryCancer, 1994
- Primary radiotherapy of breast cancer: Treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsyRadiotherapy and Oncology, 1992
- Neoadjuvant chemotherapy in 126 operable breast cancersEuropean Journal Of Cancer, 1992
- Long-term results of a combined modality approach in treating inflammatory carcinoma of the breastThe American Journal of Surgery, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapyBreast Cancer Research and Treatment, 1990
- Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapyEuropean Journal of Cancer and Clinical Oncology, 1989
- Ductal Carcinoma in Situ (Intraductal Carcinoma) of the BreastNew England Journal of Medicine, 1988
- CARCINOMA OF THE BREAST*Annals of Surgery, 1943